Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors

ACS Medicinal Chemistry Letters

Volumn 7, Issue 9, 2016, Pages 835-840

  Lu, Meng Chen ^a   Tan, Shi Jie ^a   Ji, Jian Ai ^a   Chen, Zhi Yun ^a   Yuan, Zhen Wei ^a   You, Qi Dong ^a   Jiang, Zheng Yu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Keap1; Nrf2; protein protein interaction

Indexed keywords

DDO 1018; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN INHIBITOR; TETRAZOLE DERIVATIVE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; FLUORESCENCE POLARIZATION; GENE EXPRESSION; GENE PRODUCT; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; PHYSICAL CHEMISTRY; PKA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

EID: 84986289540     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00407     Document Type: Article

References (32)

1. Kensler, T. W.; Wakabayashi, N.; Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. Toxicol. 2007, 47, 89-116 10.1146/annurev.pharmtox.46.120604.141046
2. Baird, L.; Dinkova-Kostova, A. T. The cytoprotective role of the Keap1-Nrf2 pathway Arch. Toxicol. 2011, 85, 241-72 10.1007/s00204-011-0674-5
3. Hayes, J. D.; Dinkova-Kostova, A. T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism Trends Biochem. Sci. 2014, 39, 199-218 10.1016/j.tibs.2014.02.002
4. Zhang, D. D.; Lo, S. C.; Cross, J. V.; Templeton, D. J.; Hannink, M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex Mol. Cell. Biol. 2004, 24, 10941-53 10.1128/MCB.24.24.10941-10953.2004
5. Kobayashi, A.; Kang, M. I.; Watai, Y.; Tong, K. I.; Shibata, T.; Uchida, K.; Yamamoto, M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1 Mol. Cell. Biol. 2006, 26, 221-9 10.1128/MCB.26.1.221-229.2006
6. Tong, K. I.; Katoh, Y.; Kusunoki, H.; Itoh, K.; Tanaka, T.; Yamamoto, M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model Mol. Cell. Biol. 2006, 26, 2887-900 10.1128/MCB.26.8.2887-2900.2006
7. Baird, L.; Lleres, D.; Swift, S.; Dinkova-Kostova, A. T. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 15259-64 10.1073/pnas.1305687110
8. Baird, L.; Swift, S.; Lleres, D.; Dinkova-Kostova, A. T. Monitoring Keap1-Nrf2 interactions in single live cells Biotechnol. Adv. 2014, 32, 1133-1144 10.1016/j.biotechadv.2014.03.004
9. Suzuki, T.; Motohashi, H.; Yamamoto, M. Toward clinical application of the Keap1-Nrf2 pathway Trends Pharmacol. Sci. 2013, 34, 340-346 10.1016/j.tips.2013.04.005
10. Lu, M.-C.; Ji, J.-A.; Jiang, Z.-Y.; You, Q.-D. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update. Med. Res. Rev., published online May 18, 2016; DOI: 10.1002/med.21396.
11. Lu, M.-C.; Ji, J.-A.; Jiang, Y.-L.; Chen, Z.-Y.; Yuan, Z.-W.; You, Q.-D.; Jiang, Z.-Y. An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis Sci. Rep. 2016, 6, 26585 10.1038/srep26585
12. Magesh, S.; Chen, Y.; Hu, L. Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents Med. Res. Rev. 2012, 32, 687-726 10.1002/med.21257
13. Wilson, A. J.; Kerns, J. K.; Callahan, J. F.; Moody, C. J. Keap calm, and carry on covalently J. Med. Chem. 2013, 56, 7463-76 10.1021/jm400224q
14. Richardson, B. G.; Jain, A. D.; Speltz, T. E.; Moore, T. W. Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway Bioorg. Med. Chem. Lett. 2015, 25, 2261-8 10.1016/j.bmcl.2015.04.019
15. Hancock, R.; Schaap, M.; Pfister, H.; Wells, G. Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity Org. Biomol. Chem. 2013, 11, 3553-7 10.1039/c3ob40249e
16. Hancock, R.; Bertrand, H. C.; Tsujita, T.; Naz, S.; El-Bakry, A.; Laoruchupong, J.; Hayes, J. D.; Wells, G. Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction Free Radical Biol. Med. 2012, 52, 444-51 10.1016/j.freeradbiomed.2011.10.486
17. Zhuang, C.; Miao, Z.; Sheng, C.; Zhang, W. Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review Curr. Med. Chem. 2014, 21, 1861-70 10.2174/0929867321666140217104648
18. Hu, L.; Magesh, S.; Chen, L.; Wang, L.; Lewis, T. A.; Chen, Y.; Khodier, C.; Inoyama, D.; Beamer, L. J.; Emge, T. J.; Shen, J.; Kerrigan, J. E.; Kong, A. N.; Dandapani, S.; Palmer, M.; Schreiber, S. L.; Munoz, B. Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction Bioorg. Med. Chem. Lett. 2013, 23, 3039-43 10.1016/j.bmcl.2013.03.013
19. Marcotte, D.; Zeng, W.; Hus, J.-C.; McKenzie, A.; Hession, C.; Jin, P.; Bergeron, C.; Lugovskoy, A.; Enyedy, I.; Cuervo, H.; Wang, D.; Atmanene, C.; Roecklin, D.; Vecchi, M.; Vivat, V.; Kraemer, J.; Winkler, D.; Hong, V.; Chao, J.; Lukashev, M.; Silvian, L. Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism Bioorg. Med. Chem. 2013, 21, 4011-4019 10.1016/j.bmc.2013.04.019
20. Sun, H.-P.; Jiang, Z.-Y.; Zhang, M.-Y.; Lu, M.-C.; Yang, T.-T.; Pan, Y.; Huang, H.-Z.; Zhang, X.-J.; You, Q.-d. Novel protein-protein interaction inhibitor of Nrf2-Keap1 discovered by structure-based virtual screening MedChemComm 2014, 5, 93-98 10.1039/C3MD00240C
21. Zhuang, C.; Narayanapillai, S.; Zhang, W.; Sham, Y. Y.; Xing, C. Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search J. Med. Chem. 2014, 57, 1121-6 10.1021/jm4017174
22. Davies, T. G.; Wixted, W. E.; Coyle, J. E.; Griffiths-Jones, C.; Hearn, K.; McMenamin, R.; Norton, D.; Rich, S. J.; Richardson, C.; Saxty, G.; Willems, H. M. G.; Woolford, A. J. A.; Cottom, J. E.; Kou, J.-P.; Yonchuk, J. G.; Feldser, H. G.; Sanchez, Y.; Foley, J. P.; Bolognese, B. J.; Logan, G.; Podolin, P. L.; Yan, H.; Callahan, J. F.; Heightman, T. D.; Kerns, J. K. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery J. Med. Chem. 2016, 59, 3991-4006 10.1021/acs.jmedchem.6b00228
23. Lu, M.-C.; Yuan, Z.-W.; Jiang, Y.-L.; Chen, Z.-Y.; You, Q.-D.; Jiang, Z.-Y. A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides Mol. BioSyst. 2016, 12, 1378-1387 10.1039/C6MB00030D
24. Jiang, Z.-Y.; Lu, M.-C.; Xu, L. L.; Yang, T.-T.; Xi, M.-Y.; Xu, X.-L.; Guo, X.-K.; Zhang, X.-J.; You, Q.-D.; Sun, H.-P. Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis J. Med. Chem. 2014, 57, 2736-2745 10.1021/jm5000529
25. Jiang, Z. Y.; Xu, L. L.; Lu, M. C.; Chen, Z. Y.; Yuan, Z. W.; Xu, X. L.; Guo, X. K.; Zhang, X. J.; Sun, H. P.; You, Q. D. Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor J. Med. Chem. 2015, 58, 6410-6421 10.1021/acs.jmedchem.5b00185
26. Jiang, Z.-Y.; Xu, L.-L.; Lu, M.-C.; Pan, Y.; Huang, H.-Z.; Zhang, X.-J.; Sun, H.-P.; You, Q.-D. Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis J. Comput.-Aided Mol. Des. 2014, 28, 1233-1245 10.1007/s10822-014-9799-y
27. Lu, M.; Chen, Z.; Wang, Y.; Jiang, Y.; Yuan, Z.; You, Q.; Jiang, Z. Binding Thermodynamics and Kinetics Guided Optimization of Potent Keap1-Nrf2 Peptide Inhibitors RSC Adv. 2015, 5, 85983-85987 10.1039/C5RA16262A
28. Inoyama, D.; Chen, Y.; Huang, X.; Beamer, L. J.; Kong, A. N.; Hu, L. Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction J. Biomol. Screening 2012, 17, 435-47 10.1177/1087057111430124
29. Jnoff, E.; Albrecht, C.; Barker, J. J.; Barker, O.; Beaumont, E.; Bromidge, S.; Brookfield, F.; Brooks, M.; Bubert, C.; Ceska, T.; Corden, V.; Dawson, G.; Duclos, S.; Fryatt, T.; Genicot, C.; Jigorel, E.; Kwong, J.; Maghames, R.; Mushi, I.; Pike, R.; Sands, Z. A.; Smith, M. A.; Stimson, C. C.; Courade, J. P. Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complex ChemMedChem 2014, 9, 699-705 10.1002/cmdc.201300525
30. Jain, A. D.; Potteti, H.; Richardson, B. G.; Kingsley, L.; Luciano, J. P.; Ryuzoji, A. F.; Lee, H.; Krunic, A.; Mesecar, A. D.; Reddy, S. P.; Moore, T. W. Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators Eur. J. Med. Chem. 2015, 103, 252-268 10.1016/j.ejmech.2015.08.049
31. Xi, M.-y.; Sun, Z.-y.; Sun, H.-p.; Jia, J.-m.; Jiang, Z.-y.; Tao, L.; Ye, M.; Yang, X.; Wang, Y.-j.; Xue, X.; Huang, J.-j.; Gao, Y.; Guo, X.-k.; Zhang, S.-l.; Yang, Y.-r.; Guo, Q.-l.; Hu, R.; You, Q.-d. Synthesis and bioevaluation of a series of α-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I) Eur. J. Med. Chem. 2013, 66, 364-371 10.1016/j.ejmech.2013.06.007
32. Xi, M. Y.; Jia, J. M.; Sun, H. P.; Sun, Z. Y.; Jiang, J. W.; Wang, Y. J.; Zhang, M. Y.; Zhu, J. F.; Xu, L. L.; Jiang, Z. Y.; Xue, X.; Ye, M.; Yang, X.; Gao, Y.; Tao, L.; Guo, X. K.; Xu, X. L.; Guo, Q. L.; Zhang, X. J.; Hu, R.; You, Q. D. 3-Aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as Potent Nrf2/ARE Inducers in Human Cancer Cells and AOM-DSS Treated Mice J. Med. Chem. 2013, 56, 7925-7938 10.1021/jm400944k